GlaxoSmithKline (GSK) Consumer Healthcare will purchase Biotene, a leading dry mouth treatment, from Laclede for $170 million, the company announced. The transaction is subject to regulatory review by ...
There can be many causes of dry mouth, including medication side effects, certain medical conditions or lifestyle choices. It can also be extremely uncomfortable and lead to embarrassing cosmetic ...
LONDON (Reuters) - GlaxoSmithKline Plc is acquiring Biotene, a leading over-the-counter treatment for dry mouth, for $170 million in a move to bolster its consumer healthcare business. The world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback